Provided by Tiger Trade Technology Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.2780
-0.0433-13.48%
Post-market: 0.28950.0115+4.14%16:59 EST
Volume:14.55M
Turnover:4.16M
Market Cap:31.69M
PE:-0.64
High:0.3100
Open:0.2910
Low:0.2500
Close:0.3213
52wk High:2.17
52wk Low:0.2500
Shares:114.00M
Float Shares:111.00M
Volume Ratio:1.82
T/O Rate:13.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4340
EPS(LYR):-0.9026
ROE:-916.17%
ROA:-130.48%
PB:6.97
PE(LYR):-0.31

Loading ...

Reviva Pharm Holdings Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Oct 27

Reviva Pharmaceuticals Holdings Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Oct 25

Reviva Pharmaceuticals Warned by Nasdaq Over Minimum Bid Price Compliance

Reuters
·
Oct 18

Reviva to Participate in Key Opinion Leader Webinar Hosted by Alliance Global Partners

GlobeNewswire
·
Oct 08

Reviva to Participate in the 4th Annual Roth Healthcare Opportunities Conference

GlobeNewswire
·
Oct 02

Reviva Pharm Holdings Initiated at Buy by Chardan Capital

Dow Jones
·
Sep 29

Chardan Initiates Reviva Pharmaceuticals Holdings at Buy With $2 Price Target

MT Newswires Live
·
Sep 29

Reviva Pharmaceuticals Lowers Stockholder Meeting Quorum to One-Third

Reuters
·
Sep 27

Reviva to Participate in the Lytham Partners Fall 2025 Investor Conference

GlobeNewswire
·
Sep 23

Crude Oil Down 1%; Lennar Earnings Miss Views

Benzinga
·
Sep 20

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Sep 19

Reviva Pharmaceuticals Prices $9 Million Public Offering

MT Newswires Live
·
Sep 19

Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $9 Million Public Offering

THOMSON REUTERS
·
Sep 19

Reviva Pharmaceuticals Plans Public Offering of Shares, Warrants

MT Newswires Live
·
Sep 19

Reviva Pharmaceuticals Shares Down 23% After the Bell; Announces Proposed Public Offering

THOMSON REUTERS
·
Sep 19

Reviva Pharmaceuticals announces common stock, warrants offering

TIPRANKS
·
Sep 19

Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering

GlobeNewswire
·
Sep 19

Reviva Pharm Holdings Is Maintained at Speculative Buy by Benchmark

Dow Jones
·
Sep 15

Reviva Pharmaceuticals Holdings Inc : Benchmark Cuts Target Price to $7 From $14

THOMSON REUTERS
·
Sep 15

Reviva Pharm Holdings Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 18